Header Logo

Connection

ANNIKA SILFVAST-KAISER to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications ANNIKA SILFVAST-KAISER has written about Antibodies, Monoclonal, Humanized.
ANNIKA SILFVAST-KAISER
Connection Strength
0.138
Antibodies, Monoclonal, Humanized
  1. Anti-IL17 therapies for psoriasis. Expert Opin Biol Ther. 2019 01; 19(1):45-54.
    View in: PubMed
    Score: 0.107
  2. Ixekizumab in the treatment of moderate-to-severe plaque psoriasis: Patient adherence, satisfaction, and preferences. Dermatol Ther. 2021 01; 34(1):e14486.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.